Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses

Recent international epidemics of coronavirus-associated illnesses underscore the urgent medical and public health need for vaccine development and regulatory body approved therapies. In particular, the current coronavirus disease 2019 (COVID-19) pandemic has quickly intensified interest in developi...

Descripción completa

Detalles Bibliográficos
Autores principales: Amirian, E. Susan, Levy, Julie K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118644/
https://www.ncbi.nlm.nih.gov/pubmed/32258351
http://dx.doi.org/10.1016/j.onehlt.2020.100128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118644/
https://www.ncbi.nlm.nih.gov/pubmed/32258351
http://dx.doi.org/10.1016/j.onehlt.2020.100128

Ejemplares similares